BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
April 4, 2007
View Archived Issues
Gene Therapy Gains Boost With $690M Collaboration
LONDON - Big pharma has publicly embraced gene therapy for the first time, with the signing of a $690 million deal between Sanofi-Aventis SA and Oxford BioMedica plc for TroVax. (BioWorld International)
Read More
CardioVascular Seeks AIM Status To Negate Naked Short Selling
Read More
New Enzyme Technology Could Solve Blood Supply Problems
Read More
Evotec Acquires Neuro3d Cash, Assets For $29.4M In Stock
Read More
EU Creating Registry To Boost Coordination Of Stem Cell Work
Read More
Advanced Therapies Rule Hits New EU Problems
Read More
MilleGen and LFB Partner On New Generation of MAbs
Read More
Pfizer Initiates Development Of NicOx Glaucoma Drug Candidate
Read More
Other News To Note
Read More
Nitec Pharma Gets $26M For Lodotra Development
Read More
Affibody Issues $28.5M In Shares To Boost New Diagnostic Tool
Read More